secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beam Therapeutics Inc. (BEAM)
CIK:        0001745999
Form:       8-K
Filed at:   2024-12-04T23:59:59+00:00
Accession:  0001193125-24-270314
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Beam Therapeutics appoints Chirfi Guindo to board of directors
--------------------------------------------------------------

- Chirfi Guindo, chief marketing officer of Human Health at Merck, appointed to Beam's board.
- Board expanded from seven to eight members; Guindo elected as Class I director effective Dec. 2, 2024.
- Guindo brings 25+ years at Merck and Biogen, expertise in global strategy and commercial operations.
- He will serve on the Compensation Committee of the board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1745999/000119312524270314/0001193125-24-270314-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1745999/000119312524270314/d912801d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-270314

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer